基本信息
浏览量:1
职业迁徙
个人简介
Dr Grant Parnell is a Lecturer in Bioinformatics at the School of Medical Sciences, Faculty of Medicine and Health, University of Sydney and a research group leader with a strong focus on the translation of transcriptomic and genomic technologies into clinical practice. He leads the Immunogenetics Group based at the Centre for Immunology and Allergy Research at the Westmead Institute for Medical Research. The aim of his current research program is to investigate the role of the vitamin D receptor in myeloid cell differentiation and immunological tolerance, using ATACseq, ChIPseq and RNAseq. He is also involved in projects aimed at understanding the interaction between multiple sclerosis risk genes with environmental risk factors such as low vitamin D level and Epstein-Barr virus infection.
Grant was awarded his PhD from the University of Sydney in 2014 for his work on transcriptome profiling of the immune response in patients admitted to intensive care due to systemic infection. This research identified distinct differences in the immune response in patients with pneumonia caused by bacterial as opposed to influenza infection. As part of this work, a single gene biomarker, IFI27, was identified that is capable of stratification of severity of infection in influenza infected individuals. He is a co-inventor on an international patent awarded for this biomarker. His research to date has required development of expertise in experimental design, laboratory procedures, and bioinformatics analysis for large scale transcriptomic studies. He was responsible for both his PhD lab and current research group’s transition from microarray based to next-generation sequencing transcriptomic approaches, both wet-and-dry lab aspects.
Grant was awarded his PhD from the University of Sydney in 2014 for his work on transcriptome profiling of the immune response in patients admitted to intensive care due to systemic infection. This research identified distinct differences in the immune response in patients with pneumonia caused by bacterial as opposed to influenza infection. As part of this work, a single gene biomarker, IFI27, was identified that is capable of stratification of severity of infection in influenza infected individuals. He is a co-inventor on an international patent awarded for this biomarker. His research to date has required development of expertise in experimental design, laboratory procedures, and bioinformatics analysis for large scale transcriptomic studies. He was responsible for both his PhD lab and current research group’s transition from microarray based to next-generation sequencing transcriptomic approaches, both wet-and-dry lab aspects.
研究兴趣
论文共 67 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Heba Alenezi,Grant Parnell,Stephen Schibeci,Jerome Ozkan, Mark Willcox,Andrew J R White, Nicole Carnt
Frontiers in cellular and infection microbiology (2024): 1346821-1346821
Clinical & translational immunologyno. 6 (2023)
MULTIPLE SCLEROSIS JOURNALno. 4_SUPPL (2022): 30-30
引用0浏览0引用
0
0
MULTIPLE SCLEROSIS JOURNALno. 4_SUPPL (2022): 20-21
引用0浏览0引用
0
0
Contact Lens and Anterior Eyeno. 4 (2022): 101494-101494
MULTIPLE SCLEROSIS JOURNALno. 4_SUPPL (2022): 37-37
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn